Filing Details
- Accession Number:
- 0000874015-15-000085
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-12 19:02:37
- Reporting Period:
- 2015-11-11
- Filing Date:
- 2015-11-12
- Accepted Time:
- 2015-11-12 19:02:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874015 | Isis Pharmaceuticals Inc | ISIS | Pharmaceutical Preparations (2834) | 330336973 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1206369 | Iii Joseph Klein | C/O Isis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-11-11 | 3,750 | $9.30 | 9,293 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-11-11 | 3,750 | $64.18 | 5,543 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2015-11-11 | 3,125 | $12.94 | 8,668 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-11-11 | 3,125 | $64.18 | 5,543 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Director Stock Option (right to buy) | Disposition | 2015-11-11 | 3,750 | $0.00 | 3,750 | $9.30 |
| Common Stock | Director Stock Option (right to buy) | Disposition | 2015-11-11 | 3,125 | $0.00 | 3,125 | $12.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2015-07-01 | 2021-06-30 | No | 4 | M | Direct |
| 2,812 | 2013-07-02 | 2022-07-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 100 | Indirect | By Son |
Footnotes
- Acquired as a result of exercising a stock option.
- The sale was made pursuant to shares owned.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.03 to $64.44, inclusive. The reporting person undertakes to provide to Isis Pharmaceuticals, Inc., any security holder of Isis Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) on this Form 4.
- Grant of 7/2/2012 to reporting person of stock options under the Isis Pharmacueticals, Inc. Amended & Restated 2002 Non-Employee Directors' Stock Option Plan. The option vests and becomes exercisable in four equal annual installments, the first installment vesting on 7/2/2013. The option shall be fully vested and exercisable on 7/2/2016. Following this transaction, the stock option was exercisable as to 0 shares on 11/11/2015.
Billionaire Hedge Funds
